Skip to Content
Merck
  • Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice.

Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice.

American journal of physiology. Endocrinology and metabolism (2012-05-25)
Jonathan C Jun, Mi-Kyung Shin, Qiaoling Yao, Shannon Bevans-Fonti, James Poole, Luciano F Drager, Vsevolod Y Polotsky
ABSTRACT

Obstructive sleep apnea (OSA) induces intermittent hypoxia (IH) during sleep and is associated with elevated triglycerides (TG). We previously demonstrated that mice exposed to chronic IH develop elevated TG. We now hypothesize that a single exposure to acute hypoxia also increases TG due to the stimulation of free fatty acid (FFA) mobilization from white adipose tissue (WAT), resulting in increased hepatic TG synthesis and secretion. Male C57BL6/J mice were exposed to FiO(2) = 0.21, 0.17, 0.14, 0.10, or 0.07 for 6 h followed by assessment of plasma and liver TG, glucose, FFA, ketones, glycerol, and catecholamines. Hypoxia dose-dependently increased plasma TG, with levels peaking at FiO(2) = 0.07. Hepatic TG levels also increased with hypoxia, peaking at FiO(2) = 0.10. Plasma catecholamines also increased inversely with FiO(2). Plasma ketones, glycerol, and FFA levels were more variable, with different degrees of hypoxia inducing WAT lipolysis and ketosis. FiO(2) = 0.10 exposure stimulated WAT lipolysis but decreased the rate of hepatic TG secretion. This degree of hypoxia rapidly and reversibly delayed TG clearance while decreasing [(3)H]triolein-labeled Intralipid uptake in brown adipose tissue and WAT. Hypoxia decreased adipose tissue lipoprotein lipase (LPL) activity in brown adipose tissue and WAT. In addition, hypoxia decreased the transcription of LPL, peroxisome proliferator-activated receptor-γ, and fatty acid transporter CD36. We conclude that acute hypoxia increases plasma TG due to decreased tissue uptake, not increased hepatic TG secretion.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glyceryl trioleate, ≥99%
Sigma-Aldrich
Glyceryl trioleate, ≥97.0% (TLC)
Sigma-Aldrich
Glyceryl trioleate, ~65%
Sigma-Aldrich
Anti-Actin antibody, Mouse monoclonal, clone AC-40, purified from hybridoma cell culture